Colossal Biosciences is a biotechnology and genetic engineering company focused on de-extinction and conservation biology. It aims to bring back extinct species such as the woolly mammoth, the Tasmanian tiger, and the dodo through genetic engineering and reproductive technology.

Colossal Biosciences

The science of genetics. The business of discovery.Colossal is a breakthrough bioscience and genetic engineering company that builds radical new technologies to advance the field of genomics. Colossal creates disruptive technologies for extinct species restoration, critically endangered species protection and the repopulation of critical ecosystems that support the continuation of life on Earth. The company is the first to apply CRISPR technology for the purposes of species de-extinction, beginning with the woolly mammoth. Colossal is accepting humanity’s duty to restore Earth to a healthier state, while also solving for the future economies and biological necessities of the human condition through cutting-edge science and technologies.

Draper Associates

First Light Capital

Winklevoss Capital

Jazz Venture Partners

Animal Capital

At One Ventures

Liquid 2 Ventures

Bold Capital Partners

Breyer Capital

Thomas Tull

Animoca Brands

Green Sands Equity

Boost VC

cFund

Paris Hilton

Robert Nelsen

US Innovative Technology Fund

WestRiver Group

Peak 6

In-Q-Tel

Bob Nelsen

Elias Montanari

Sahin Boydas

Victor Vescovo

COM:COLOSSAL

Colossal Biosciences

Financials Not Available